Avro Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Avro Life Sciences's estimated annual revenue is currently $3.3M per year.
- Avro Life Sciences's estimated revenue per employee is $155,000
Employee Data
- Avro Life Sciences has 21 Employees.
- Avro Life Sciences grew their employee count by -9% last year.
Avro Life Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, COO | Reveal Email/Phone |
2 | Scientist | Reveal Email/Phone |
3 | Research Associate | Reveal Email/Phone |
4 | Scientist I | Reveal Email/Phone |
5 | Analytical Chemist | Reveal Email/Phone |
Avro Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Avro Life Sciences?
Medical device/biopharmaceutical startup developing medicated stickers capable of delivering antihistamines and other small molecules to children. Target markets: Children, elderly, bariatric patients, dysphagia sufferers Part of the Velocity Incubator, Communitech network, and Bayer Grants4Apps accelerator
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avro Life Sciences News
2022-04-13 - Global Bioinformatics Market Analysis 2022-2026: A $21.32 ...
... Sparse Vector, Avro, Parquet and ORC (Optimized Row Compressed). ... Tripos; LP; Helicos Biosciences Incorporation; IBM Life Sciences.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 21 | -5% | N/A |
#2 | $1.7M | 21 | 0% | N/A |
#3 | $1.6M | 22 | 57% | N/A |
#4 | $5.5M | 22 | -4% | N/A |
#5 | $1.8M | 22 | -4% | N/A |